Study Looks at Co-Use of CYP2D6-Metabolizing Opioids, Antidepressants in Seniors
MONDAY, July 22, 2024 (HealthDay News) -- For older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is associated with worsening pain and increased risk of opioid-related adverse events (ORAEs),...